Account
Insider Insights
20.04.2022
Access to cancer drugs

According to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...

Read more
Insider Insights
19.04.2022
Payment model to be launched for antibiotics

The UK looks set to become the first country in the world to use a subscription-style payment model ...

Read more
Insider Insights
14.04.2022
Latest survey shows disparities in access

The study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...

Read more
Insider Insights
11.04.2022
Streamline negotiation of price conditions

The amendment includes a number of articles which aims to “streamline the negotiation of the price...

Read more
Insider Insights
06.04.2022
Cancer report recommends access to new treatments

The report looks at how differences in cancer survival rates between the UK and other countries have...

Read more
Insider Insights
05.04.2022
IPCEI to promote development of gene and cell ther

The IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...

Read more
Insider Insights
25.03.2022
UK-wide commitments for genomics initiatives

According to the Department of Health and Social Care (DHSC), the commitments will enable patients t...

Read more
Insider Insights
24.03.2022
Manufacturer paybacks of E1 billion in relation to

Consequently, paybacks from pharmaceutical manufacturers of around €1 billion will be due from pha...

Read more
Insider Insights
24.03.2022
“First of its kind” MAA leads to NICE approval

The draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...

Read more
Insider Insights
21.03.2022
Early access agreement

Patients in England will be the first in Europe to have access to Takeda’s Exkivity (mobocertinib)...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.